Theramex, one of the largest suppliers of hormone replacement therapy (HRT) in the UK, agreed to purchase the European rights ...

Generic drugmaker Viatris (NASDAQ:VTRS) has been £1.5M by the U.K.'s Competition and Markets Authority (CMA) for failing to comply with compulsory restrictions imposed during the regulator’s review of ...